Sucampo Pharma (SCMP) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
UPDATE: Cantor Fitzgerald Downgrades Sucampo Pharmaceuticals (SCMP) to Hold
May 7, 2015 6:59 AM EDT(Updated - May 7, 2015 9:24 AM EDT)
Cantor Fitzgerald downgraded Sucampo Pharmaceuticals (NASDAQ: SCMP) from Buy to Hold. Comments follow mixed Q1 results. Analyst Irina Rivkind Koffler views shares as fully valued and thinks the stock will trade range-bound.
"Sucampo reported revenues of $29.5... More



